Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Chimeric antigen receptor T-cell therapy induces complete remission in a patient with concurrent CLL with CNS involvement and multiple sclerosis.
Journal: Leukemia & lymphoma
Published: June 07, 2026
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial.
Journal: The Lancet. Haematology
Published: September 18, 2025
Enhanced CAR T-Cell Therapy for Lymphoma after Previous Failure.
Journal: The New England journal of medicine
Published: May 07, 2025
Aleukemic soft-tissue relapse post allogeneic hematopoietic cell transplantation in T-prolymphocytic leukemia.
Journal: Leukemia & lymphoma
Published: February 08, 2025
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial.
Journal: Haematologica
Published: April 26, 2024
Cardiotoxicity from bruton tyrosine kinase inhibitors (BTKi)-an analysis of an administrative health claims database.
Journal: Cardio-oncology (London, England)
Published: February 12, 2024
Bendamustine as Lymphodepletion for Brexucabtagene Autoleucel Therapy of Mantle Cell Lymphoma.
Journal: Transplantation and cellular therapy
Published: January 11, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy.
Journal: Nature medicine
Published: December 19, 2023
PD-L1+ diffuse large B-cell lymphoma with extremely high mutational burden and microsatellite instability due to acquired PMS2 mutation.
Journal: Cold Spring Harbor molecular case studies
Published: October 31, 2023
Last Updated: 09/26/2026